Design, synthesis and biological evaluation of novel pyridine derivatives as gut-selective NaPi2b inhibitors

Bioorg Med Chem Lett. 2022 Jun 1:65:128700. doi: 10.1016/j.bmcl.2022.128700. Epub 2022 Mar 25.

Abstract

We previously reported thiophene derivatives as gut-selective (minimally systemic) and potent sodium-dependent phosphate transport protein 2b (SLC34A2, NaPi2b) inhibitors. However, these derivatives did not suppress phosphate absorption form the intestinal tract in Sprague-Dawley (SD) rats. The lack of efficacy in vivo could be due to the high hydrophobicity of these compounds. In this report, we identified novel pyridine derivatives as gut-selective NaPi2b inhibitors with good activity in vitro and relatively low hydrophobicity. Especially, gut-selective compound 20b suppressed phosphate absorption in SD rats. These results suggest that physical properties, such as the hydrophobicity of the compounds, might affect the in vivo efficacy.

Keywords: Bioavailability; Gut-selective; Hyperphosphatemia; NaPi2b; NaPi2b inhibitor.

MeSH terms

  • Animals
  • Phosphates* / metabolism
  • Pyridines* / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Thiophenes

Substances

  • Phosphates
  • Pyridines
  • Thiophenes
  • pyridine